Point72 (ANGO) reports 3.18M shares, 7.7% stake via Point72 Associates
Point72 Asset Management, along with Point72 Capital Advisors Inc. and Steven A. Cohen, has reported a beneficial ownership of 3,181,829 shares in AngioDynamics (ANGO), representing a 7.7% stake as of March 31, 2026. These shares are held through Point72 Associates, an investment fund managed by Point72 Asset Management, and involve shared voting and dispositive power. The filing clarifies the control relationships among the reporting entities, with Steven A. Cohen controlling both Point72 Asset Management and Point72 Capital Advisors Inc., but explicitly states that the reporting persons do not directly own these shares.
FEB 23·Stock Titan→
Hear AngioDynamics CEO Jim Clemmer live at Leerink healthcare conference
AngioDynamics (NASDAQ: ANGO) President and CEO, Jim Clemmer, will present at the Leerink Partners Global Healthcare Conference on Monday, March 9, 2026, at 1:40 p.m. ET. A live webcast of the presentation will be available on the company's website. AngioDynamics specializes in medical technology for vascular systems, cancer treatment, and patient quality of life.
JAN 7·kare11.com▼
AngioDynamics: Fiscal Q2 Earnings Snapshot
AngioDynamics Inc. (ANGO) reported a fiscal second-quarter loss of $6.4 million, or 15 cents per share, adjusting to less than 1 cent per share for specific costs. The medical device maker announced revenue of $79.4 million and anticipates full-year losses between 23 to 33 cents per share, with revenue guidance of $312 million to $314 million. Its shares have grown 3% year-to-date and 46% over the past 12 months.
